CTOs on the Move

RenalGuard Solutions

www.renalguard.com

 
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Andrew Halpert
 Chief Technology Officer Profile

Funding

RenalGuard Solutions raised $14.5M on 03/16/2017

Similar Companies

AMR Medical /AR Technologies Company (ARTCO)

AMR Medical /AR Technologies Company (ARTCO) is a Fresno, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mitchell Planning

Mitchell Planning is a Northbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zenflow

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.

Osada

Osada is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SteadyMed

SteadyMed Therapeutics, Inc. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs. Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications: Extending the limits of parenteral therapeutics to restore freedom, joy and dignity to patients’ lives.